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ABSTRACT 
A growing range of brain-computer interface (BCI) technologies is being employed for 
purposes of therapy and human augmentation. While much thought has been given to the 
ethical implications of such technologies at the ‘macro’ level of social policy and ‘micro’ level of 
individual users, little attention has been given to the unique ethical issues that arise during the 
process of incorporating BCIs into eHealth ecosystems. In this text a conceptual framework is 
developed that enables the operators of eHealth ecosystems to manage the ethical components 
of such processes in a more comprehensive and systematic way than has previously been 
possible. The framework’s first axis defines five ethical dimensions that must be successfully 
addressed by eHealth ecosystems: 1) beneficence; 2) consent; 3) privacy; 4) equity; and 5) 
liability. The second axis describes five stages of the systems development life cycle (SDLC) 
process whereby new technology is incorporated into an eHealth ecosystem: 1) analysis and 
planning; 2) design, development, and acquisition; 3) integration and activation; 4) operation 
and maintenance; and 5) disposal. Known ethical issues relating to the deployment of BCIs are 
mapped onto this matrix in order to demonstrate how it can be employed by the managers of 
eHealth ecosystems as a tool for fulfilling ethical requirements established by regulatory 
standards or stakeholders’ expectations. Beyond its immediate application in the case of BCIs, 
we suggest that this framework may also be utilized beneficially when incorporating other 
innovative forms of information and communications technology (ICT) into eHealth 
ecosystems. 
 
Keywords: eHealth ecosystems; brain-computer interfaces (BCIs); systems development life cycle 
(SDLC); health care ethics; business ethics; IT management; technological innovation 
INTRODUCTION  
A diverse and growing array of brain-computer interface (BCI) technology is being employed for 
purposes of therapy and, increasingly, human augmentation. Much thought has been given to the 
ethical aspects of BCIs; however, such ethical analyses typically view BCIs from the perspective of 
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policymakers who must decide whether or not such technologies should be legal or of individual users 
for whom a BCI creates new opportunities and risks. Relatively little attention has been given to the 
ethical aspects of BCIs from the perspective of the managers of eHealth ecosystems who are charged 
with successfully incorporating new forms of information and communications technology (ICT) like 
BCIs into those environments. Such a lack of research and best practices is problematic, given the fact 
that managers who handle the practical details of implementing BCIs within eHealth ecosystems may 
discover ethical issues that were not foreseen by policymakers and which ordinary end users are not 
able to fully appreciate and resolve due to a lack of technical expertise. 
In this text we seek to formulate a tool that can aid such managers in their work of incorporating BCIs 
and other innovative new forms of ICT into an eHealth ecosystem in a way that systematically 
diagnoses and addresses the unique ethical questions that are relevant for each stage of such a process. 
We begin by defining eHealth ecosystems and presenting an overview of BCIs and the roles that they 
can fill in such ecosystems. The ethical aspects of BCIs are then investigated by means of a novel two-
dimensional framework that surfaces and analyzes ethical issues relating to ICT in eHealth ecosystems 
through the lens of a systems development life cycle (SDLC) approach to technology management. 
DEFINING EHEALTH ECOSYSTEMS 
It is difficult to identify a single universally accepted definition of ‘eHealth.’ Pagliari (2005) cites 36 
definitions of eHealth found within the scientific literature and other sources. While those definitions 
differ greatly, many of them include a number of common themes, including an emphasis on the use of 
Internet-based and other networked ICT (as opposed to standalone technologies such as non-
networked scanning equipment); telemedicine; and the creation, transmission, and analysis of digital 
data to enhance both the provision of medical treatment and the performance of administrative tasks. 
Having considered many such definitions of eHealth, Whitehouse and Duquenoy (2008) cite as 
especially useful the definition contained in the European Commission’s Action Plan for a European e-
Health Area (COM (2004) 356 final, p. 4), which states that eHealth “describes the application of 
information and communications technologies across the whole range of functions that affect the health 
sector.” 
An eHealth ‘ecosystem’ can be understood as a networked environment of actors, devices, and 
information systems involved in the provisioning of eHealth services that display both autonomy and 
mutual dependencies and which interact in such complex ways that they can ‘evolve’ in a manner 
analogous to that of a natural biological ecosystem (Benedict and Schlieter, 2015; Guedria et al., 2014). 
Such ecosystems can incorporate actors such as patients, primary care professionals, public hospitals, 
G
la
dd
en
, M
at
th
ew
 E
., 
"M
an
ag
in
g 
th
e 
Et
hi
ca
l D
im
en
sio
ns
 o
f B
ra
in
-C
om
pu
te
r I
nt
er
fa
ce
s 
in
 e
H
ea
lth
: A
n 
SD
LC
-b
as
ed
 A
pp
ro
ac
h,
" 
 
in
 9
th
 A
nn
ua
l E
ur
oM
ed
 A
ca
de
m
y 
of
 B
us
in
es
s 
C
on
fe
re
nc
e:
 In
no
va
tio
n,
 E
nt
re
pr
en
eu
rs
hi
p 
an
d 
D
ig
ita
l E
co
sy
ste
m
s 
(E
U
RO
M
ED
 2
01
6)
 B
oo
k 
of
 P
ro
ce
ed
in
gs
, 
ed
ite
d 
by
 D
em
et
ris
 V
ro
nt
is,
 Y
aa
ko
v 
W
eb
er
, a
nd
 E
va
ng
el
os
 T
so
uk
at
os
, E
ng
om
i: 
Eu
ro
M
ed
 P
re
ss
, 2
01
6,
 p
p.
 8
89
-9
02
.
9th Annual Conference of the EuroMed Academy of Business                                                      862 
 
Innovation, Entrepreneurship and Digital Ecosystems                             ISBN: 978-9963-711-43-7 
 
private outpatient clinics, diagnostic and imaging facilities, nursing homes, pharmacies, universities, 
research laboratories, insurers, and national and local government agencies (Nollo et al., 2014). These 
actors interact through the use of ICT that includes medical devices housed in dedicated facilities (such 
as fMRI machines), mobile health devices (such as wearable heart monitors), home fitness equipment, 
cloud-based health care information systems, and general-purpose communication tools such as social 
media, email, and telephones (Guedria et al., 2014; Nollo et al., 2014). Such tools are used to deliver 
business outcomes including real-time telemonitoring and teleassistance, patient education, 
management of patient care, and financial processing (Guedria et al., 2014). 
In order to be viable, an eHealth ecosystem must possess legal, organizational, semantic, and technical 
interoperability among its constituent devices, processes, and systems (Guedria et al., 2014; COM (2010) 
744 final, Dec. 2010). When implemented on the smallest scale, it is possible for such an ecosystem to 
constitute a ‘personal’ eHealth ecosystem (Harno, 2013) that connects all of the implantable, wearable, 
mobile, or ambient devices involved with the provision of health care to a single individual. When 
implemented on a larger scale, such ecosystems may operate at a municipal, national, or international 
level and include millions of patients as members. Bourquard (2011, p. 84) notes, for example, that the 
development of pan-European eHealth ecosystems will require successful agreement on international 
standards such as the EU eHealth Interoperability Framework envisioned by the European 
Commission (Van Langenhove et al., 2013), development of a consensus implementation roadmap by 
service providers, creation of testing platforms, and creation of certification regimes to enforce 
convergence and consistency. 
OVERVIEW OF BRAIN-COMPUTER INTERFACES AND THEIR (POTENTIAL) 
ROLES IN EHEALTH ECOSYSTEMS 
Brain-computer interfaces (BCIs) comprise a diverse and expanding range of sophisticated 
neurotechnologies whose use is expected to increasingly impact spheres of human activity including 
health care; interpersonal relationships and sociality; creativity and the arts; science, education, and 
knowledge management; commerce, work and organizational life; and defense, law enforcement, and 
personal security (Gladden, 2016). BCIs are devices that “involve real-time direct connections between 
the brain and a computer” (Glannon, 2014, p. 1) and which “provide a direct communication pathway 
between the human brain and an external device” (Lance et al., 2012, p. 1586). A BCI can be classified as 
‘invasive,’ ‘non-invasive,’ or ‘partially invasive’ depending on whether the device physically extends 
into the tissue of its user’s brain (Gasson, 2012, p.14; Panoulas et al., 2010; Gladden, 2015). Non-invasive 
BCIs (e.g., utilizing EEG or fMRI technology) may involve sensors temporarily affixed to a user’s scalp, 
while invasive BCIs (e.g., for deep brain stimulation) may incorporate hundreds of electrodes or other 
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stimulators or sensors surgically implanted in a user’s brain (Glannon, 2014, p. 1; Bostrom and 
Sandberg, 2009). BCIs are employed for functions including neurofeedback, neurostimulation, and 
neural control of remote devices (Haselager et al., 2009, p. 1352). 
There is a wide variety of roles that BCIs are already playing or can potentially play within eHealth 
ecosystems. Perhaps the most obvious role for BCIs is in the direct provision of care to treat a medical 
condition. For example, some kinds of cochlear implants (Bostrom and Sandberg, 2009, p. 321) and 
artificial retinas (see Thanos et al., 2007) can interface directly with the brain to provide sense data from 
the external environment to users who would otherwise be unable to hear or see. Deep brain 
stimulation (DBS) is used to treat motor disorders such as Parkinson’s disease, dystonia, and essential 
tremor (Clausen, 2011, p. 495). BCIs can also potentially be employed to predict or stop epileptic 
seizures (Drongelen et al., 2005; Fountas and Smith, 2007). New kinds of BCIs are being envisioned in 
the form of cognitive neuroprostheses that can support, regulate, modify, or replace neural processes 
relating to memory, imagination, emotion, identity, and consciousness (Gladden, 2016). 
BCIs can also allow patients suffering from particular medical conditions to control computerized 
systems that are external to their bodies. For example, BCIs can be utilized to control motorized 
wheelchairs and robotic artificial limbs, which can be used by paralyzed patients for self-feeding and 
other important tasks (Clausen, 2011, pp. 498-99; Glannon, 2014, p. 1). BCIs can also be directly 
employed by patients as a means of communication. For example, a BCI can be used by a paralyzed 
individual to control a cursor on a computer screen (Glannon, 2014, p. 1) in order to compose messages. 
BCIs can also be employed to communicate with patients suffering from paralysis or locked-in 
syndrome (LIS) who would otherwise be unable to communicate (Haselager et al., 2009, p. 1353; 
Glannon, 2014, p. 1). 
Increasingly, though, BCIs will be used not for the therapeutic purpose of treating a medical condition 
but in order to augment and enhance the cognitive and physical capacities of healthy human beings 
(Gasson, 2012, p. 25). This is expected to create radical new possibilities for incorporating BCIs into the 
activities of eHealth ecosystems. For example, it is anticipated that in the future, medical personnel 
could use BCIs as a replacement for smartphones to engage in real-time, hands-free, direct brain-to-
brain communication with one another or to check online medical reference texts with a mere thought 
(Lance et al., 2015; Gladden, 2015). Medical personnel could also use BCIs as a means of authenticating 
their identity and accessing restricted services and data within eHealth ecosystems – including financial 
and administrative data, patients’ medical histories, and real-time data from monitoring devices, as 
well as remotely controlling diagnostic equipment, drug delivery systems, implantable medical 
devices, and robotic surgical systems (Thorpe et al., 2005; Van Erp et al., 2012; Gladden, 2015). 
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THE LACK OF TOOLS AND APPROACHES FOR MANAGING THE ETHICAL 
DIMENSIONS OF INCORPORATING BCIS INTO EHEALTH ECOSYSTEMS 
The use of BCIs raises many complex ethical and legal questions relating to safety and risk, privacy, 
personal identity and agency, equity and social justice, and the nature and future direction of the 
human species. Many works have explored such ethical dimensions of BCIs, including those by Nijboer 
et al. (2006), McGee and Maguire (2007), Wolpe (2007), Bostrom and Sandberg (2009), Haselager et al. 
(2009), Tamburrini (2009), Kotchetkov et al. (2010), Clausen (2011), Vlek et al. (2012), Jebari (2013), 
Nijboer et al. (2013), Glannon (2014), and McCullagh et al. (2014). However, such works typically focus 
either on the ethical issues that are relevant at a societal level (e.g., evaluating whether certain kinds of 
BCIs should be banned by the government) or at the personal level (e.g., considering the impact of a 
BCI on the privacy and autonomy of an individual patient). Significant attention has not yet been given 
to ethical issues that arise at the organizational level when managing the implementation of BCIs – and 
in particular, scholars have not yet systematically identified or considered unique ethical issues that 
might arise when managing the incorporation of BCIs into eHealth ecosystems. 
This lack of research and established best practices relating to the ethical management of eHealth 
technology implementation concerns not only BCIs but innovative forms of ICT more generally. For 
example, numerous works have explored the ethical aspects of eHealth, including those by Rippen and 
Risk (2000), Anderson (2007), Whitehouse and Duquenoy (2008), Liang, Mackey, and Lovett (2011), 
Kluge (2011), Whitehouse, George, and Duquenoy (2012), Duquenoy, Mekawie, and Springett (2013), 
Miesperä, Ahonen, and Reponen (2013), Wadhwa and Wright (2013), Habib (2014), Jumelle and Ispas 
(2015), and Rissanen (2015). However, as broad investigations of ethical issues in eHealth, such texts do 
not provide operators of eHealth ecosystems with comprehensive frameworks for surfacing and 
managing the spectrum of unique ethical considerations that arise at each stage of the process of 
incorporating new ICT into such ecosystems. 
FORMULATING AN SDLC-BASED ETHICAL FRAMEWORK FOR MANAGING 
THE INCORPORATION OF INNOVATIVE ICT INTO EHEALTH  
In order to address this lacuna in the fields of BCI implementation and eHealth management, we 
propose a conceptual framework for managing the incorporation of innovative ICT into eHealth that 
is based on a systems development life cycle (SDLC) approach and which can be applied directly to 
the case of BCIs. Our two-dimensional framework encompasses: 1) key ethical dimensions relevant to 
the management of eHealth ecosystems; and 2) stages in the process of incorporating a new kind of 
ICT into an eHealth ecosystem. This framework is described in more detail below. 
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First Axis: Ethical Dimensions of Incorporating Innovative ICT into an eHealth Ecosystem 
A review was conducted of the two dozen texts cited above that discuss the ethical dimensions of BCIs 
or of the incorporation of innovative forms of ICT into eHealth ecosystems. Within the constraints of 
this text, it is not possible to describe and compare in detail the contents of those texts; however, by 
analyzing and synthesizing such works, it is possible to delineate five key ethical dimensions that must 
be successfully addressed when incorporating innovative ICT into eHealth ecosystems; these are: 1) 
beneficence, 2) consent, 3) privacy, 4) equity, and 5) liability. 
Second Axis: SDLC Stages of Incorporating Innovative ICT into an eHealth Ecosystem  
Incorporating insights from the systems development life cycle (SDLC) approach to technology 
management, the second axis of our framework describes five key stages of implementing new ICT in 
an eHealth ecosystem. Wager et al. (2013) review a range of SDLC frameworks that have been 
employed to manage the development of health care information systems; they observe that most 
approaches can be summarized as comprising the four stages of planning and analysis, design, 
implementation, and support and evaluation. Similarly, Benedict and Schlieter (2015, pp. 236-37) 
identify four stages in the creation of the infrastructure for an open eHealth ecosystem: analysis, design, 
implementation and testing, and utilization. Meanwhile, an SDLC developed by the US National 
Institute of Standards and Technology with an emphasis on information security similarly describes the 
four phases of initiation, development/acquisition, implementation, and operations/maintenance, along 
with an additional phase of disposal (NIST SP 800-100, 2006, pp. 19-25): information systems do not last 
forever, and it is important that once they reach the end of their service life their components are 
disposed of in a manner involving appropriate information preservation and media sanitization. This is 
especially critical in the case of health care information systems that contain personal medical data 
subject to stringent legal and ethical requirements (Gladden, 2015, pp. 180-81). 
By synthesizing such SDLC frameworks, we can describe the five relevant stages of incorporating ICT 
into an eHealth ecosystem as comprising: 1) analysis and planning; 2) design, development, and acquisition; 
3) integration and activation; 4) operation and maintenance; and 5) disposal. 
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Figure 1. Figure 1. Our proposed framework for managing the ethical dimensions of incorporating innovative 
ICT into eHealth ecosystems, as applied to the case of brain-computer interface technologies. Shown are 
examples of issues relating to all five ethical dimensions at each of the five stages of the system development 
life cycle (SDLC) when incorporating a new BCI technology into an eHealth ecosystem. 
Combining the Two Axes to Yield a Matrix of Ethical Issues for Each Stage of the SDLC 
When combined, the axes described above yield a matrix of the sort reflected in Figure 1. It defines an 
array onto which can be mapped ethical issues relating to a particular form of ICT. We would suggest 
that such a framework can potentially be used as an effective management tool for surfacing, 
classifying, and addressing unique ethical issues that should be considered during each stage of the 
process of incorporating innovative ICT into an eHealth ecosystem. 
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APPLYING THE ETHICAL FRAMEWORK TO MANAGING THE EHEALTH 
IMPLEMENTATION OF BCIS 
Having formulated this framework, we can apply it to the particular case of incorporating BCI 
technology into an eHealth ecosystem. A number of ethical questions that have been raised (sometimes 
in an ad hoc fashion) in the literature on BCIs and eHealth ecosystems; in Figure 1, we have populated 
our matrix with such issues by assigning them to the relevant location within the two-dimensional 
space. In the following sections, the ethical issues related to each SDLC stage will be discussed in more 
detail, illustrating the manner in which this framework might aid eHealth ecosystems’ operators in 
managing in a systematic and comprehensive way the ethical dimensions of integrating BCI 
technologies into such ecosystems. 
SDLC Stage 1: The Analysis and Planning Stage 
In this stage, key ethical questions may be addressed by international, national, and local policymakers 
in consultation with the program managers who would ultimately oversee the incorporation of BCI 
technologies into an eHealth ecosystem. To begin with, the ethical dimension of beneficence is important 
in this stage: decision-makers must assess whether incorporating BCI technology into an eHealth 
ecosystem is likely to do significant good (and acceptably minimal harm) for its users. For example, use 
of an invasive BCI that requires implanted electrodes is inherently risky; it can cause brain trauma and 
hemorrhage in otherwise healthy patients (Clausen, 2011, p. 499). If the benefits generated by the BCI 
do not outweigh this risk (perhaps, e.g., in the case of BCIs used to grant enhanced communication 
capacities to healthy human beings (Clausen, 2011, p. 499)), it may be decided not to endorse, 
encourage, or allow the use of such BCIs by facilitating their incorporation into an eHealth ecosystem. 
The element of users’ consent is also relevant at a systemic level even in this first stage. Decision-makers 
must consider the extent to which the incorporation of BCIs into an ecosystem is being driven by users’ 
legitimate needs and desires and to what extent users may have been manipulated by device 
manufacturers (e.g., through advertising campaigns) to feel as though they ‘need’ a BCI in order to be 
happy or successful (Bostrom and Sandberg, 2009, p. 324). If the best and most effective health care 
systems employ widespread BCIs for the provisioning of care, individuals may feel pressured to utilize 
such technologies in order to access adequate care. If it is apparent that users of a BCI technology will 
not be truly free to grant or withhold consent, it may be inadvisable to proceed with its incorporation 
into an eHealth ecosystem. 
During this stage, the ethical element of privacy is addressed by developing effective policies, practices, 
and roles to ensure that users’ data will be protected throughout the later stages of the SDLC. The 
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element of equity is addressed by identifying relevant stakeholders (including ethicists, legal scholars, 
biomedical experts, hospitals, potential device users, and device manufacturers) and gathering their 
input before any major programmatic commitments are made. Many BCI technologies are quite 
expensive: decision-makers must consider how their incorporation into eHealth ecosystems may 
unfairly advantage those who can afford to purchase them and may increase disparities between 
financially privileged and disadvantaged individuals within society (Bostrom and Sandberg, 2009, p. 
329) or between wealthier and poorer countries. Decision-makers must also consider the impact that 
incorporation of a BCI will have on those within the eHealth ecosystem who choose not to utilize such 
technologies: if BCIs become an important element of an ecosystem, then unwillingness to use a BCI 
might effectively deprive a patient of full access to the health care system (Bostrom and Sandberg, 2009, 
p. 329). Decision-makers must also ask whether BCIs are being used as an easy means of controlling or 
pacifying patients that avoids addressing broader medical or societal issues (Bostrom and Sandberg, 
2009, p. 324). 
Issues of liability must also be discussed at a systemic level, to clarify who will bear responsibility for all 
decisions and actions taken throughout the incorporation process. Moreover, in addition to addressing 
ethical concerns that are unique to the analysis and planning stage, during this stage decision-makers 
must also conduct a preliminary analysis of all of the ethical issues that are expected to arise during 
later stages – to be sure that none of those ethical issues is so severe that it warrants abandoning the BCI 
incorporation at this first stage. 
SDLC Stage 2: The Design, Development, and Acquisition Stage 
During the design, development, and acquisition stage of the SDLC, beneficence is addressed, for 
example, by ensuring that BCIs and the mechanisms incorporating them into an eHealth ecosystem 
possess appropriate failure modes that will minimize harm to users in the case of software errors, 
mechanical failures, or other problems (Gladden, 2015, p. 259), as well as testing BCIs to ensure that 
they do not generate unexpectedly harmful side-effects (Bostrom and Sandberg, 2009, p. 323). Consent 
includes obtaining the informed consent of all individuals who serve as test subjects during design and 
testing of the BCI incorporation. Privacy involves not only safeguarding the privacy of such test subjects 
but also ensuring that BCIs and their system connections are built to include adequate management, 
operational, and technical controls for information security (Gladden, 2015, pp. 205-304).  
Questions of equity include ensuring that BCIs and their connections to an eHealth ecosystem are 
designed to work equally well for diverse kinds of users and that they do not unfairly advantage 
specific device manufacturers or users who possess a particular socioeconomic status, place of 
G
la
dd
en
, M
at
th
ew
 E
., 
"M
an
ag
in
g 
th
e 
Et
hi
ca
l D
im
en
sio
ns
 o
f B
ra
in
-C
om
pu
te
r I
nt
er
fa
ce
s 
in
 e
H
ea
lth
: A
n 
SD
LC
-b
as
ed
 A
pp
ro
ac
h,
" 
 
in
 9
th
 A
nn
ua
l E
ur
oM
ed
 A
ca
de
m
y 
of
 B
us
in
es
s 
C
on
fe
re
nc
e:
 In
no
va
tio
n,
 E
nt
re
pr
en
eu
rs
hi
p 
an
d 
D
ig
ita
l E
co
sy
ste
m
s 
(E
U
RO
M
ED
 2
01
6)
 B
oo
k 
of
 P
ro
ce
ed
in
gs
, 
ed
ite
d 
by
 D
em
et
ris
 V
ro
nt
is,
 Y
aa
ko
v 
W
eb
er
, a
nd
 E
va
ng
el
os
 T
so
uk
at
os
, E
ng
om
i: 
Eu
ro
M
ed
 P
re
ss
, 2
01
6,
 p
p.
 8
89
-9
02
.
9th Annual Conference of the EuroMed Academy of Business                                                      869 
 
Innovation, Entrepreneurship and Digital Ecosystems                             ISBN: 978-9963-711-43-7 
 
residence, or set of mental and physical characteristics. Issues of liability include specifying liability for 
any accidents that might occur during testing of BCIs and their incorporation into eHealth ecosystems 
and developing clear liability frameworks for later stages in the implementation process. 
SDLC Stage 3: The Integration and Activation Stage 
The integration and activation stage involves connecting BCIs to an eHealth ecosystem and its services 
for the first time or activating features within the eHealth ecosystem that allow BCI users to 
individually connect to the system. In this stage, the dimension of beneficence involves ensuring that the 
initial integration of BCIs into the ecosystem does not cause harm to the BCIs’ users or other 
participants in the ecosystem (e.g., through a lack of bandwidth or computer resources needed to 
simultaneously support the BCIs and all other ecosystem components). Consent requires that the BCIs 
of individual users not be accessed by or functionally integrated into an ecosystem (e.g., through 
remote management or participation in cloud-based services) without users’ knowledge and 
agreement. The ability of minors and those with cognitive disorders to give informed consent for 
integration of their BCIs into an ecosystem may be nonexistent (Bostrom and Sandberg, 2009, p. 324). 
Clausen (2011, pp. 498-99) notes the special ethical issues raised by BCIs that are used to establish 
communication with patients who are otherwise unable to communicate, such as those suffering from 
locked-in syndrome: by definition, such patients are unable to express their consent before a BCI is 
installed and activated. While activating such a BCI – especially an invasive one – without a patient’s 
consent could be considered unethical, refusing to apply such a beneficial life-enhancing technology 
because the patient is unable to express consent in advance might also be considered ethically 
inappropriate. 
During the integration and activation stage, privacy requires not only that an ecosystem appropriately 
safeguard the particular data generated by a user’s BCI but also that the mere fact that someone 
possesses a BCI and has become a member of the ecosystem be kept confidential. Equity requires that 
the order and robustness with which classes of BCIs and individual users’ BCIs are incorporated into 
an eHealth ecosystem be determined in a manner that is just and not unlawfully discriminatory. 
Questions of liability are addressed by ensuring that clear legal frameworks and particular agreements 
are in place before an institutional or individual operator of BCIs or provider of BCI-related services is 
allowed to access an eHealth ecosystem. 
SDLC Stage 4: The Operation and Maintenance Stage 
During this stage, BCIs participate fully in an eHealth ecosystem while being actively employed by 
their operators and users for a range of therapeutic and augmentative tasks. Here, beneficence requires 
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that both BCIs and other components of the eHealth ecosystem (including any centralized management 
systems) respond effectively to changing real-time conditions to optimize service and risk levels, 
maximize the benefit, and minimize the potential of harm for BCIs’ users. For example, eHealth 
ecosystem operators may need to monitor BCI users to detect whether use of the devices is generating 
addictions or harmful personality changes (Clausen, 2011, p. 499). Even non-invasive BCIs designed for 
seemingly harmless purposes may be employed by their users in ways that raise ethical questions for 
an ecosystem’s managers. For example, BCIs ostensibly designed for educational purposes may yield 
more knowledgeable users but can also potentially generate negative effects such as increased 
selfishness, extremism, confusion, or manipulability (Bostrom and Sandberg, 2009, pp. 322-23). 
Moreover, if BCIs are used to link human minds to create a ‘collective intelligence’ of direct brain-to-
brain communication, an ecosystem’s operator may be responsible for preventing such interaction from 
erupting into the sort of ‘flame wars’ and trolling that are commonly found on the Internet and which 
can cause “stress and unpleasantness for everyone involved” (Bostrom and Sandberg, 2009, p. 322) – 
especially given some BCIs’ powerful ability to force incoming communications into a user’s immediate 
conscious awareness. 
Bostrom and Sandberg note that economic competition and the need to secure and maintain a job 
might eventually force individuals to utilize BCIs who would otherwise never voluntarily choose to use 
them (Bostrom and Sandberg, 2009, p. 328; Gladden, 2016). Similarly, if the best and most effective 
health care ecosystems employ widespread BCIs for the provisioning of care, individuals may feel 
pressured to utilize such technologies in order to access adequate care. This raises questions of consent 
that must be monitored and addressed by an eHealth ecosystem’s operators. 
Moreover, BCIs in use generate large quantities of sensitive information (e.g., about a user’s mental 
states, physical activities, social interactions, location, and environment) whose privacy must be 
safeguarded within an eHealth ecosystem. For example, even BCIs that do not typically create a 
permanent recording of a patient’s electroencephalographic signals may do so during a device’s 
training phase (e.g., when a patient is learning to control a motor prosthesis); Clausen (2011, p. 498) 
raises the ethical question of whether employers and insurers should be allowed to access such 
information. BCIs can also potentially be utilized by criminal hackers and other adversaries as a new 
and more effective tool for accessing or manipulating the data of an eHealth ecosystem’s members – 
including those who do not possess BCIs (Gladden, 2015). 
Ensuring equity in this stage involves guaranteeing that the providers of BCIs or BCI-related services do 
not take advantage of their possession of sensitive user data or users’ physical and psychological 
dependency on such devices (Bostrom and Sandberg, 2009, p. 323) to unjustly exploit or extort their 
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users. Issues of liability are also important; for example, a BCI that allows a paralyzed patient to steer a 
motorized wheelchair must continuously detect and interpret the patient’s brain signals, and the 
system will inevitably make errors that occasionally cause the wheelchair to move in an unintended 
manner, thereby potentially causing accidents that harm persons or property. Clausen (2011, p. 499) 
notes that a majority of surveyed BCI experts would attribute responsibility for such accidents to a 
system’s user (Nijboer et al., 2013), but insurance companies or other participants in an ecosystem 
might instead be assigned responsibility.  
SDLC Stage 5: The Disposal Stage 
The ethical factor of beneficence requires that before managers and decision-makers permanently 
remove or limit the existing connection of BCIs to an eHealth ecosystem, they first ascertain whether 
such actions may cause immediate or future harm to the users of those devices (Gladden, 2015, p. 175). 
Given the fact that both the use of certain kinds of BCIs as well as the discontinuation of their use can 
have profound psychological and physical effects on their users, it may be necessary to obtain the 
consent of individual BCI users before changes are made to an eHealth ecosystem that result in a loss of 
BCIs’ ability to interface with the system and utilize its services. In some cases, it may be unethical to 
disable or disconnect a BCI against its user’s will, even when the device no longer serves the medical 
purpose for which it was originally prescribed (Clausen, 2011, p. 499). 
In this stage, the ethical dimension of privacy involves ensuring that sensitive user data generated by 
BCIs’ interaction with the eHealth ecosystem and stored within the system is permanently safeguarded, 
even after the BCIs’ ability to participate in the ecosystem has been terminated. The ethical dimension 
of equity involves determining in a fair and impartial way which BCI services and interfaces are to be 
discontinued – e.g., as a result of budgetary constraints in managing an ecosystem. The ethical 
dimension of liability is reflected, for example, in questions of financial and legal responsibility for any 
harm occurring to individual users or their property due to actions by an ecosystem’s operators that 
result in the disconnection or disabling of BCIs participating in the system (Bostrom and Sandberg, 
2009, p. 323).  
CONCLUSION 
When seeking to incorporate innovative forms of ICT like brain-computer interface technologies into 
eHealth ecosystems, the operators of such ecosystems must grapple with a complex array of ethical 
questions that are not directly and comprehensively addressed by existing approaches within business 
ethics, health care ethics, and the ethics of BCIs. By utilizing a framework such as the one formulated in 
this text, managers can systematically identify ethical issues relating to BCIs and understand them as 
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questions of beneficence, consent, privacy, equity, and liability which can be addressed as they become 
relevant during the SDLC stages of analysis and planning; design, development, and acquisition; integration 
and activation; operation and maintenance; and disposal. It is hoped that this framework may facilitate the 
incorporation of beneficial BCI technologies into eHealth ecosystems in ways that fulfill ethical 
demands arising from regulatory requirements and the expectations for best practices on the part of 
stakeholders including patients, medical personnel, government policymakers, taxpayers, device 
manufacturers, and ecosystem operators. The application of this management tool in the case of BCIs 
may also lay the groundwork for its use when integrating other forms of innovative ICT into eHealth 
ecosystems. Giving the growing social and economic significance of advanced health care within aging 
societies, the expanding role of BCIs in facilitating the provision of high-quality health care, and 
emerging possibilities for the use of BCIs in human augmentation, the importance of conceptual 
frameworks that can assist eHealth ecosystem operators in managing the ethical dimensions of such 
sophisticated technologies is only likely to grow in the coming years. 
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